Trials / Terminated
TerminatedNCT00444834
A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension
A Phase II, Multi-center, Multiple-dose, Double-blind, Randomized, Crossover Study Comparing the Pharmacodynamic Effects of a Once-daily Controlled-Release Carvedilol (CRC; Egalet® Formulation) and an Immediate-Release Carvedilol (IRC) Formulation in Patients With Primary Hypertension
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Egalet Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the efficacy of the Egalet® controlled release formulation to an immediate release Carvedilol tablet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carvedilol | 50 mg |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-05-01
- Completion
- 2007-05-01
- First posted
- 2007-03-08
- Last updated
- 2016-08-29
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00444834. Inclusion in this directory is not an endorsement.